- Home
- ORGO vs HZO Comparison
ORGO vs HZO Comparison
Compare ORGO & HZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- HZO
- Stock Information
- Founded
- ORGO 1985
- HZO 1998
- Country
- ORGO United States
- HZO United States
- Employees
- ORGO N/A
- HZO N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- HZO Auto & Home Supply Stores
- Sector
- ORGO Health Care
- HZO Consumer Discretionary
- Exchange
- ORGO Nasdaq
- HZO Nasdaq
- Market Cap
- ORGO 376.8M
- HZO 450.3M
- IPO Year
- ORGO N/A
- HZO 1998
- Fundamental
- Price
- ORGO $2.92
- HZO $21.95
- Analyst Decision
- ORGO Buy
- HZO Strong Buy
- Analyst Count
- ORGO 2
- HZO 6
- Target Price
- ORGO $5.50
- HZO $38.50
- AVG Volume (30 Days)
- ORGO 1.6M
- HZO 251.4K
- Earning Date
- ORGO 05-08-2025
- HZO 07-24-2025
- Dividend Yield
- ORGO N/A
- HZO N/A
- EPS Growth
- ORGO N/A
- HZO N/A
- EPS
- ORGO N/A
- HZO 2.44
- Revenue
- ORGO $458,760,000.00
- HZO $2,420,818,000.00
- Revenue This Year
- ORGO $2.73
- HZO $0.08
- Revenue Next Year
- ORGO $12.28
- HZO $3.66
- P/E Ratio
- ORGO N/A
- HZO $8.96
- Revenue Growth
- ORGO 5.35
- HZO N/A
- 52 Week Low
- ORGO $2.28
- HZO $16.85
- 52 Week High
- ORGO $6.71
- HZO $38.20
- Technical
- Relative Strength Index (RSI)
- ORGO 35.44
- HZO 49.51
- Support Level
- ORGO $2.61
- HZO $20.52
- Resistance Level
- ORGO $3.28
- HZO $22.21
- Average True Range (ATR)
- ORGO 0.14
- HZO 0.74
- MACD
- ORGO 0.01
- HZO -0.09
- Stochastic Oscillator
- ORGO 34.59
- HZO 39.74
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About HZO MarineMax Inc. (FL)
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.